Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2000
05/09/2000US6060469 Spiro-piperidine derivatives and their use as tachykinin antagonists
05/09/2000US6060468 N-substituted azaheterocyclic compounds
05/09/2000US6060460 Use of betaglycan to reduce scarring
05/09/2000US6060250 Human transferases
05/09/2000CA2151560C Insulin analog formulations
05/09/2000CA2129679C Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
05/09/2000CA2112239C Enantiomeric hydroxylated xanthine compounds
05/09/2000CA2084412C Pyrrolidine and thiazolidine amides
05/09/2000CA1340987C Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime, processof preparation, their use as medicine and compositions containing same
05/09/2000CA1340986C 1,2,5,6,-tetrahydropyridine derivatives, method for preparing same, their use as medicine and compositions containing same
05/04/2000WO2000025138A2 Methods of diagnosing or prognosing alzheimer's disease
05/04/2000WO2000024911A2 Human phospholipases
05/04/2000WO2000024897A1 Cell surface molecule-induced macrophage activation
05/04/2000WO2000024886A1 Prv-1 gene and the use thereof
05/04/2000WO2000024880A1 Transgenic c. elegans as a model organism for research into alzheimer's disease
05/04/2000WO2000024745A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
05/04/2000WO2000024744A1 Bicyclic nitrogen heterocycles
05/04/2000WO2000024743A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
05/04/2000WO2000024742A1 Pyrazolopyridine as adenosine antagonists
05/04/2000WO2000024741A2 Dihydropyridine compounds and their use as potassium channel openers
05/04/2000WO2000024719A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
05/04/2000WO2000024718A1 Serine protease inhibitor
05/04/2000WO2000024717A2 Isoquinoline derivatives
05/04/2000WO2000024716A1 Dihydropyridine derivatives and drug compositions containing the same
05/04/2000WO2000024400A1 Use of optically pure (r)-tofisopam for treating and preventing anxiety disorders and composition thereof
05/04/2000WO2000024393A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
05/04/2000WO2000024392A1 β-AMYLOID FORMATION INHIBITORS
05/04/2000WO2000024390A1 Method and composition for modulating amyloidosis
05/04/2000WO2000024386A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs
05/04/2000WO2000024373A1 O/w emulsion comprising an hydroxylated oil
05/04/2000WO2000024362A2 Δ9 tetrahydrocannabinol (δ9 thc) solution metered dose inhalers and methods of use
05/04/2000WO2000007997A8 IMIDAZOLES AND RELATED COMPOUNDS AS α1A AGONISTS
05/04/2000WO2000006730A3 Human cytoskeletal proteins
05/04/2000WO2000006579A3 Pyrrolo[2,1-b][1,3]benzothiazepines with atypical antipsychotic activity
05/04/2000WO2000006254A3 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
05/04/2000WO2000006187A3 Modulation of apoptosis
05/04/2000WO2000006139A3 Use of moclobemide and metabolites for treating and preventing substance abuse
05/04/2000WO2000006085A3 Compounds and methods
05/04/2000WO2000006082A3 Treatment of anxiety disorders
05/04/2000WO2000004868A3 Libraries of polyhydroxamates and their analogs
05/04/2000WO2000002917A3 Compounds and methods for modulating cadherin-mediated functions
05/04/2000WO2000002897B1 Delta cleavage products and methods based thereon
05/04/2000WO2000002547A3 The treatment of renal colic with gaba analogs
05/04/2000WO1999066959A3 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival
05/04/2000WO1999064038A9 Novel analgesic agents
05/04/2000WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS
05/04/2000WO1999062888A8 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
05/04/2000WO1999062879A8 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres
05/04/2000WO1999061066A3 Convection-enhanced delivery of aav vectors
05/04/2000WO1999059573A9 Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
05/04/2000WO1998019513A3 Method for the preparation of citalopram
05/04/2000DE19850072A1 Phosphinat-Peptidanaloga zur Behandlung von fibrotischen Erkrankungen Phosphinate-peptide analogues in the treatment of fibrotic diseases
05/04/2000DE19835910C1 Gen isoliert auf dem kurzen Arm des menschlichen Chromosoms 17 Gene isolated on the short arm of human chromosome 17
05/04/2000CA2349211A1 Prv-1 gene and the use thereof
05/04/2000CA2348833A1 Human phospholipases
05/04/2000CA2348576A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
05/04/2000CA2348281A1 Use of optically pure (r)-tofisopam for treating and preventing anxiety disorders and composition thereof
05/04/2000CA2348165A1 Dihydropyridine compounds and methods of use
05/04/2000CA2348019A1 Method and composition for modulating amyloidosis
05/04/2000CA2347982A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
05/04/2000CA2347365A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
05/04/2000CA2347032A1 O/w emulsion comprising an hydroxylated oil
05/04/2000CA2346990A1 Serine protease inhibitor
05/04/2000CA2344637A1 .delta.9 tetrahydrocannabinol (.delta.9 thc) solution metered dose inhalers and methods of use
05/04/2000CA2343100A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs
05/04/2000CA2249648A1 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
05/03/2000EP0997477A2 MHC complexes and uses thereof
05/03/2000EP0997464A1 1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists
05/03/2000EP0997149A1 Compositions comprising guggul extract and phosphate salts
05/03/2000EP0996733A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human
05/03/2000EP0996731A2 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
05/03/2000EP0996626A1 Glycine transporter
05/03/2000EP0996622A1 Novel spiroazabicyclic heterocyclic compounds
05/03/2000EP0996620A1 Novel compounds
05/03/2000EP0996619A1 Tropane analogs and methods for inhibition of monoamine transport
05/03/2000EP0996618A1 Endothelin antagonists: n- 2'- (4,5-dimethyl-3-isoxazolyl) amino]sulfonyl]-4-(2-oxazolyl) 1,1'-biphenyl]-2-yl]methyl] -n,3,3-trimethylbutanamide and n-(4,5-dimethyl-3-isoxazolyl) -2'- (3,3-dimethyl-2-oxo-1-pyrrolidinyl) methyl] -4'-(2-oxazolyl) 1,1'-biphenyl]-2-sulfonamide and salts thereof
05/03/2000EP0996613A1 Tramadol, salts thereof and process for their preparation
05/03/2000EP0996612A2 Aliphatic propargylamines as cellular rescue agents
05/03/2000EP0996468A1 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics
05/03/2000EP0996466A2 Novel composition comprising an ssri and a beta-blocker
05/03/2000EP0996463A2 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions
05/03/2000EP0996456A1 Methods for treating neurological deficits
05/03/2000EP0996446A1 Novel substituted imidazole compounds
05/03/2000EP0996440A1 Method for treatment of glutamate related disorders
05/03/2000EP0743940B1 New compounds with analgesic and local anaesthetic effect
05/03/2000EP0719767B1 Succinamic acid compound, process for producing the same, and use thereof
05/03/2000EP0691985B1 Phosphonomethyldipeptides
05/03/2000EP0514481B1 Merosin, nucleic acids encoding, fragments and uses thereof
05/03/2000CN1252070A 5,7-disubstituted 4-aminopyrido [2,3,-d] pyrimidine compounds and their use as adenosine kinase inhibitors
05/03/2000CN1252069A 5,6,7-trisubstituted-4-aminopyrido [2,3-d] pyrimidine compounds
05/03/2000CN1252061A 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-thiones derivatives, their preparation and use as dopamine autoreceptor (D2) agonists
05/03/2000CN1252060A 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives, their preparation and use as dopamine autoreceptor (D2) agonists
05/03/2000CN1252049A 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives
05/03/2000CN1251999A Stable extract of hypericum perforatum L.,method for producing same and corresponding pharmaceutical preparations
05/03/2000CN1251745A Carotenoid preparation having mixture of beta-carotene, lycopene and xanthophyll
05/03/2000CN1052003C Prodrugs of antiinflammatory 3-acyl-2-oxidole-1-carboxamides
05/03/2000CN1051935C Chinese herbal medicine for senile dementia and preparation thereof
05/03/2000CN1051934C Chinese herbal medicine for epiplepsy and its preparation
05/03/2000CN1051933C Traditional Chinese medicine composition for treating refractory headache
05/02/2000US6057454 1-oxo-1H-inden-2-yl-1H-imidazole-2-carboxylic acid intermediates
1 ... 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 ... 1833